EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aquaporin-4 in Stroke and Brain Edema—Friend or Foe?

Cecilia Alejandra García Ríos, Jose E Leon-Rojas iD

International Journal of Molecular Sciences · 23.08.2025 · 26 (17) · 8178

DOI: 10.3390/ijms26178178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.08.2025. Verfasst von Cecilia Alejandra García Ríos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Carrera de Medicina, Facultad Ciencias de la Salud, Universidad Nacional de Chimborazo (UNACH), Riobamba 060108, Ecuador. Hauptthemen laut MEDLINE: Aquaporin 4, Brain Edema, Stroke. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de las Américas (UDLA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke is a leading global cause of mortality and long-term disability, with cerebral edema constituting a major contributor to early neurological deterioration and poor outcomes. Aquaporin-4 (AQP4), the predominant water channel in the central nervous system, plays a paradoxical role in stroke-related brain edema, facilitating both the formation and clearance of excess fluid depending on the pathological context. This review explores the biphasic function of AQP4 across cytotoxic and vasogenic edema, emphasizing its dynamic regulation, subcellular localization, and implications for therapeutic intervention. Evidence from rodent models shows that AQP4 exacerbates cytotoxic edema in acute ischemia by promoting intracellular water influx into astrocytes, whereas in vasogenic edema, it supports fluid reabsorption and glymphatic clearance, thereby alleviating brain swelling. Human studies corroborate AQP4 upregulation in infarcted regions and suggest a potential role for AQP4 polymorphisms and circulating levels as biomarkers of stroke severity and outcome, although larger cohorts and more robust methodological designs are needed. This review also discusses emerging pharmacological strategies to modulate AQP4 activity, including inhibitors, trafficking modulators, and gene-targeted delivery systems, while highlighting challenges in achieving phase-specific modulation. Given its central role in both injury and recovery, AQP4 emerges as a promising yet complex therapeutic target for personalized management of stroke-induced brain edema. Future directions include real-time imaging of AQP4 function, genotype-stratified clinical trials, and integration of AQP4 modulation with current stroke treatment protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aquaporin 4Brain EdemaStrokeHumansAnimalsAstrocytes

Stichwörter der Autor:innen

Aquaporin-4brain edemacytotoxic edemastrokevasogenic edema

Substanzen

Aquaporin 4

Autor:innen und Institutionen

  • Carrera de Medicina, Facultad Ciencias de la Salud, Universidad Nacional de Chimborazo (UNACH), Riobamba 060108, Ecuador.
  • Cerebro, Emoción y Conducta (CEC) Research Group, Escuela de Medicina, Universidad de las Américas (UDLA), Quito 170124, Ecuador.

ORCID-Profile: Jose E Leon-Rojas

Förderung

  • Universidad de las Américas (UDLA)

Zitieren

APA

García Ríos, C. A., & Leon-Rojas, J. E. (2025). Aquaporin-4 in Stroke and Brain Edema—Friend or Foe?. International Journal of Molecular Sciences, 26(17), 8178. https://doi.org/10.3390/ijms26178178

Vancouver

García Ríos CA, Leon-Rojas JE. Aquaporin-4 in Stroke and Brain Edema—Friend or Foe?. International Journal of Molecular Sciences. 2025;26(17):8178. doi:10.3390/ijms26178178

BibTeX
@article{GarcaRos2025,
  author = {García Ríos, Cecilia Alejandra and Leon-Rojas, Jose E},
  title = {Aquaporin-4 in Stroke and Brain Edema—Friend or Foe?},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {17},
  pages = {8178},
  doi = {10.3390/ijms26178178}
}
Kostenlos starten →